Evaluating Pharmacokinetic and Pharmacodynamic Interactions with Computational Models in Supporting Cumulative Risk Assessment

By Tan Yu-Mei   Clewell Harvey   Campbell Jerry   Andersen Melvin  

International Journal of Environmental Research and Public Health, Vol. 8, Iss. 5, 2011-05 ,pp. : 1613-1630

MDPI

Access to resources Recommend Favorite

Incorporation of In Vitro Drug Metabolism Data into Physiologically-based Pharmacokinetic Models

By Houston J.B.   Carlile D.J.  

Toxicology in Vitro, Vol. 11, Iss. 5, 1997-10 ,pp. : 473-478

Elsevier

Access to resources Recommend Favorite

The Use of Background Data in Risk Assessments: Introductory Comments

By Jones Daniel S.  

Human and Ecological Risk Assessment, Vol. 9, Iss. 7, 2003-12 ,pp. : 1595-1597

Taylor & Francis Ltd

Access to resources Recommend Favorite

The application of physiologically based pharmacokinetic/pharmacodynamic (PBPK/PD) modeling for exploring risk assessment approaches of chemical mixtures

By Yang R.S.H.   El-Masri H.A.   Thomas R.S.   Constan A.A.   Tessari J.D.  

Toxicology Letters, Vol. 79, Iss. 1, 1995-09 ,pp. : 193-200

Elsevier

Access to resources Recommend Favorite

Physiologically based pharmacokinetic and pharmacodynamic modeling in health risk assessment and characterization of hazardous substances

By Hon-Wing L.   Paustenbach D.J.  

Toxicology Letters, Vol. 79, Iss. 1, 1995-09 ,pp. : 55-65

Elsevier

Access to resources Recommend Favorite